ARCHIVES

Executive Summary of Centers, SPOREs Report

This article is from The Cancer Letter archive.

Vol. 29 No. 09 | February 28, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982

Foon To Direct Barrett Center; Hundahl Leads Commission

March 5, 1999

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

New Grant Program in Physical Activity

March 28, 2003

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002